California’s legislature recently passed AB 3129, and it is awaiting Governor Gavin Newsom’s signature.
While AB 3129 impacts several different provider types, this article focuses on its impact on Management Service...more
On December 18, 2023, the California Office of Administrative Law approved the emergency regulations promulgated by the Office of Health Care Affordability (OHCA) that set forth the procedural framework for (i) the...more
On March 15, the Centers for Medicare and Medicaid Services (CMS) released guidance on the drug price negotiations provisions of the Inflation Reduction Act (IRA). The guidance contains CMS’s interpretations for a range of...more
4/4/2023
/ Acquisitions ,
Biologics ,
Biopharmaceutical ,
Centers for Medicare & Medicaid Services (CMS) ,
Clinical Trials ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
Healthcare ,
Inflation Reduction Act (IRA) ,
Investment ,
Life Sciences ,
R&D ,
Research and Development
In celebration of the 50th episode of our Diagnosing Health Care podcast, we’re looking at how the past 50 years of health law will impact health care in the next 50 years.
On this episode, Epstein Becker Green attorneys...more
On June 7, 2022, the Federal Trade Commission (FTC) unanimously voted to initiate a study into how business practices employed by some pharmacy benefit managers (PBMs) may impact prescription drug pricing and patient access...more
The $1.9 trillion coronavirus relief package, the American Rescue Plan, includes money for rural hospitals, billions of dollars for COVID-19 testing and contact tracing, and extra subsidies to help people buy health coverage...more
3/31/2021
/ Affordable Care Act ,
American Rescue Plan Act of 2021 ,
Biden Administration ,
Contact Tracing ,
Coronavirus/COVID-19 ,
Federal Funding ,
Health Care Providers ,
Health Insurance ,
Hospitals ,
Relief Measures ,
Rural Health Care Providers ,
Subsidies ,
Virus Testing
The 117th Congressional health care agenda, including COVID-19 related action, will require 60 votes in the Senate or passage through budget reconciliation. Epstein Becker Green attorneys Mark Lutes, Philo Hall, and Timothy...more
Based on their extensive experience advising health care industry clients, Epstein Becker Green attorneys and strategic advisors from EBG Advisors are predicting the “hot” health care sectors for investment, growth, and...more
1/9/2020
/ Artificial Intelligence ,
Biologics ,
Clinical Trials ,
Electronic Medical Records ,
Health Care Providers ,
Health Information Technologies ,
Health Insurance ,
Healthcare Facilities ,
Hospitals ,
Investment Opportunities ,
Long Term Care Facilities ,
Medical Devices ,
Medicare Advantage ,
Pharmaceutical Industry ,
Physicians ,
Prescription Drugs ,
Private Equity ,
Research and Development ,
Telehealth ,
Telemedicine
Two merger announcements this week—one concerning CVS’s intention to acquire Aetna and the other concerning United/Optum’s intention to acquire DaVita’s physician group—have health investors and strategists peering over the...more
An August 14 meta-analysis of payment reform evaluations by Len Nichols and others offers health care investors a sobering appraisal of the success to-date of a range of payment reforms initiated by the Centers for Medicare &...more
In the wake of the demise of recent Affordable Care Act “repeal and replace” efforts, both “skinny” and full boat, health care financial sponsors may wonder how they should be thinking about opportunities and threats related...more
The day after the 2016 U.S. presidential election, Epstein Becker Green, in conjunction with Jefferies LLC, hosted “The Ballots Are Counted: How the New Political Landscape Will Shape Health Care Investing.” The event was...more
11/21/2016
/ Administrative Appointments ,
Affordable Care Act ,
Department of Health and Human Services (HHS) ,
Health Insurance ,
Healthcare Reform ,
Legislative Agendas ,
Medicare ,
Mental Health Parity Rule ,
Presidential Elections ,
Repeal ,
Social Security ,
Trump Administration